April
2006 »
Generic drugs: decipher
between facts, fiction
18 April, 2006
One of the most frequent discussions
in pharmacy today is the one concerning generic
drugs. What are they? Are they as good? Who should
use them? I will take a few lines and try to answer
these questions.
What are they?
When patents expire on brand-name drugs, the generic
form of that drug becomes available. The patent period
is a time that the original producer of a drug is given
exclusive rights to make and sell a given product. This
period of time is 20 years from the time of invention.
This period includes all developmental time as well
as the time required for clinical studies. Usually a
drug company gets 10 years or less of exclusivity with
a drug product and is then called a "name-brand"
drug. After the patent period has expired, others drug
companies are free to make and sell the product and
the term "generic" drug is used.
Are generic drugs as good as name-brand drugs?
The answer to this question isn't absolute. Patient
and doctor preferences, cost, and product availability
affect this determination. When considering the quality
of the drug product, it is less complicated. The generic
products are as good as the name brand products. Although
the government allows as much as 20% variation in tested
parameters, when actually measured there is less than
3% difference between the two. The labels of "generic"
and "name-brand" refer more to the legal disposition
of a product as it relates to the patent period and
not to the quality level of the product. All drug makers
are required to conform to the same set of manufacturing
standards.
Who should use generic drugs?
Most consumers would choose to use generic drugs when
available. The quality of the generic choice is the
same as that of the brand-name product. The main difference
between them is the price. Generic pharmaceuticals cost
significantly less. The average cost of a generic prescription
is $14.70 while the average cost of a name-brand prescription
is $77.02. Yes, generics cost only about 20% of their
name-brand counterparts. The total drug cost of generic
prescriptions is about 19 billion dollars yearly in
the United States while the cost of name-brands is nearly
100 billion. Name-brand co-pays (what the consumer pays)
are commonly $40 to $70 per prescription. Generic co-pays
are usually $5 to $15. Exclusive or excessive use of
name-brand pharmaceuticals would rapidly bankrupt our
health care system. Many millions of generic prescriptions
are dispensed yearly with good value, effectiveness
and safety.
To read more, Visit:
http://www.tooeletranscript.com/index.php?option=content&task=view&id=12362&Itemid=
|